COMP <GO>
GWW vs TMO // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
W.W. Grainger Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: GWW 8
— TMO 6
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: GWW
LAST: $1,359.17 (-0.93%) • MKT CAP: $64.62B
options-implied-move
6.50%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
options-implied-move
6.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GWW VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GWW | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 39.10% | 41.00% | -1.90 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 35.80% | 9.30% | +26.50 | GWW | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.6x | 30.4x | -8.80 | GWW | /valuation <GO> |
| Free Cash Flow Yield | 2.06% | 2.40% | -0.34 | TMO | /fcf-yield <GO> |
| Operating Margin | 13.90% | 17.40% | -3.50 | TMO | /operating-margins <GO> |
| Net Profit Margin | 9.50% | 15.10% | -5.60 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 4.50% | 3.90% | +0.60 | GWW | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.72% | 0.24% | +0.48 | GWW | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 14.74 | 4.50 | +10.24 | GWW | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 6.50% | 6.70% | -0.20 | GWW | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.3 | 59.1 | +2.18 | GWW | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.87 | 0.94 | -0.07 | TMO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 35.2x | 36.3x | -1.10 | GWW | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $64.62B | $262.22B | -$197.60B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GWW REV | TMO REV | GWW GROSS % | TMO GROSS % | GWW FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $17.94B | $44.56B | 39.1% | 44.0% | $1.33B | $6.29B |
| FY 2024 | $17.17B | $42.88B | 39.4% | 44.0% | $1.57B | $7.27B |
| FY 2023 | $16.48B | $42.86B | 44.0% | 44.0% | $1.29B | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GWW // BETA 0.87
TMO // BETA 0.94